SCHEMBL26423261

SCHEMBL26423261

c1cnc2cc3c(cc2c1)oc1ccncc13

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.41
PDGFRA P16234 2/20 0.41
ALDH1A1 P00352 5/20 0.40
GRM4 Q14833 2/20 0.39
NPC1 O15118 2/20 0.39
POLB P06746 2/20 0.39
RAB9A P51151 1/20 0.39
CASP6 P55212 1/20 0.37
CASP1 P29466 2/20 0.37
HTT P42858 2/20 0.37
KDM4E B2RXH2 2/20 0.37
TP53 P04637 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
CASP7 P55210 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423266 0.94 PDGFRB (0.41) PDGFRBPDGFRAALDH1A1GRM4NPC1
SCHEMBL26423252 0.88 PDGFRB (0.41) PDGFRBPDGFRAALDH1A1GRM4NPC1
SCHEMBL26423212 0.83 MAPT (0.49) PDGFRBPDGFRAALDH1A1GRM4NPC1
SCHEMBL26423389 0.82 NPC1 (0.31) ALDH1A1NPC1RAB9AKDM4EMAPT
SCHEMBL13085116 0.82 KDM4E (0.39) ALDH1A1GRM4NPC1POLBRAB9A
SCHEMBL26423402 0.82 EGFR (0.39) ALDH1A1GRM4HTTKDM4EDYRK1A
SCHEMBL26423259 0.82 PDGFRB (0.41) PDGFRBPDGFRAALDH1A1GRM4NPC1
SCHEMBL26423348 0.79 ALDH1A1 (0.41) PDGFRBPDGFRAALDH1A1GRM4NPC1
SCHEMBL24911457 0.79 NR4A2 (0.56) PDGFRBPDGFRAALDH1A1NPC1POLB
SCHEMBL26423196 0.76 MAPT (0.49) PDGFRBPDGFRAALDH1A1GRM4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 PDGFRB 3044/4885PDGFRA 1639/4885ALDH1A1 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.